Relevant studies have elucidated the roles of key pathways, including CFTR ion transport, cAMP/ERK, and FXR, in CF pathogenesis and validated the therapeutic efficacy of targeted interventions. The gene discussed is NR1H4; the disease is cystic fibrosis.